Alixtra subcutaneous injection 1.5mg, from Sand Pharma, contains Fondaparinux sodium, a selective factor Xa inhibitor used to prevent and treat deep vein thrombosis and pulmonary embolism. It is an injectable drug with a YJ code of 3339400G1029 and a standard of 1.5 mg in 0.3 mL per tube.
Alixtra subcutaneous injection 1.5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).